These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 17419486)

  • 1. [Erythropoietin use in extensive surgeries on liver and pancreas].
    Severtsev AN; Chudaev DB
    Khirurgiia (Mosk); 2006; (12):33-6. PubMed ID: 17419486
    [No Abstract]   [Full Text] [Related]  

  • 2. Anemia and response to epoetin alfa: the cause of anemia matters!
    Dharmarajan TS
    J Am Geriatr Soc; 2008 Aug; 56(8):1574-5. PubMed ID: 18808607
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety concerns about perisurgical epoetin treatment: should we add antiplatelet drugs to perisurgical epoetin alfa treatment?
    Basora M; Fita G; Matute P; Díaz-Ricart M
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):623-4. PubMed ID: 17678803
    [No Abstract]   [Full Text] [Related]  

  • 5. Corticosteroids and erythropoeitin-receptor agonists.
    McLachlan CS
    CMAJ; 2008 Jan; 178(1):66. PubMed ID: 18166738
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biosimilar epoetin: a new chapter is opening].
    Del Vecchio L
    G Ital Nefrol; 2008; 25(4):385. PubMed ID: 18663682
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epoetin in cancer treatment--the end of the game?].
    Wisløff F
    Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2359. PubMed ID: 17895937
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of epoetin on survival in patients with breast cancer.
    Codacci-Pisanelli G; Spinelli GP; Tomao S
    J Clin Oncol; 2008 May; 26(15):2599; author reply 2599-600. PubMed ID: 18487580
    [No Abstract]   [Full Text] [Related]  

  • 9. The first biosimilar epoetin: but how similar is it?
    Schellekens H
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):174-8. PubMed ID: 18057303
    [No Abstract]   [Full Text] [Related]  

  • 10. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N; Sriuranpong V; Suwanrusme H
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilisation review of epoetin alfa in cancer patients at a cancer centre in Singapore.
    Chan A; Lim LL; Tao M
    Singapore Med J; 2009 Apr; 50(4):365-70. PubMed ID: 19421679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counterfeit Procrit.
    FDA Consum; 2003; 37(3):5. PubMed ID: 12793379
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietin receptors: their role beyond erythropoiesis.
    Rossert J; Eckardt KU
    Nephrol Dial Transplant; 2005 Jun; 20(6):1025-8. PubMed ID: 15840686
    [No Abstract]   [Full Text] [Related]  

  • 14. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W; Locatelli F; Ryckelynck JP; Balla J; Csiky B; Harris K; Ehrhard P; Beyer U;
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, double-blind, placebo-controlled trial of epoetin alfa in men with castration-resistant prostate cancer and anemia.
    Winquist E; Julian JA; Moore MJ; Nabid A; Sathya J; Wood L; Venner P; Levine M
    J Clin Oncol; 2009 Feb; 27(4):644-6. PubMed ID: 19103725
    [No Abstract]   [Full Text] [Related]  

  • 16. Anaemia of CKD--the CHOIR study revisited.
    Singh AK; Szczech L; Tang KL; Barnhart H; Sapp S; Wolfson M; Reddan D
    Nephrol Dial Transplant; 2007 Jul; 22(7):1806-10. PubMed ID: 17420166
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss.
    Arroliga AC; Guntupalli KK; Beaver JS; Langholff W; Marino K; Kelly K
    Crit Care Med; 2009 Apr; 37(4):1299-307. PubMed ID: 19242343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa.
    Agnihotri P; Telfer M; Butt Z; Jella A; Cella D; Kozma CM; Ahuja M; Riaz S; Akamah J
    J Am Geriatr Soc; 2007 Oct; 55(10):1557-65. PubMed ID: 17697104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver, biliary tract, and pancreas.
    Rikkers LF; Pitt HA; Warshaw AL
    Curr Opin Gen Surg; 1993; ():233-8. PubMed ID: 7583978
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative mortality and epoetin alpha dose among hemodialysis patients.
    Coyne DW
    Am J Kidney Dis; 2008 May; 51(5):866-7; author reply 867. PubMed ID: 18436101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.